Figures & data
Figure 1. Treatment schedule and division of groups for elevated plus-maze paradigm. m, minutes; TL, transfer latency; h, hours; SCO, scopolamine (1 mg/kg, i.p.); FRFE 10, 50, and 100, Ficus religiosa fig extract (10, 50, and 100 mg/kg, i.p.); CYP, cyproheptadine (4 mg/kg, i.p.).
![Figure 1. Treatment schedule and division of groups for elevated plus-maze paradigm. m, minutes; TL, transfer latency; h, hours; SCO, scopolamine (1 mg/kg, i.p.); FRFE 10, 50, and 100, Ficus religiosa fig extract (10, 50, and 100 mg/kg, i.p.); CYP, cyproheptadine (4 mg/kg, i.p.).](/cms/asset/fa32efe1-2080-4429-8826-442f433a67a6/iphb_a_427304_f0001_b.gif)
Figure 2. Treatment schedule and division of groups for modified passive avoidance paradigm. m, minutes; SDL, step down latency; NT, number of trials; NM, number of mistakes; h, hours; SCO, scopolamine (1 mg/kg, i.p.); FRFE 10, 50, and 100, Ficus religiosa fig extract (10, 50, and 100 mg/kg, i.p.); CYP, cyproheptadine (4 mg/kg, i.p.).
![Figure 2. Treatment schedule and division of groups for modified passive avoidance paradigm. m, minutes; SDL, step down latency; NT, number of trials; NM, number of mistakes; h, hours; SCO, scopolamine (1 mg/kg, i.p.); FRFE 10, 50, and 100, Ficus religiosa fig extract (10, 50, and 100 mg/kg, i.p.); CYP, cyproheptadine (4 mg/kg, i.p.).](/cms/asset/5b4336c3-1c85-4b59-870d-673f7a785a00/iphb_a_427304_f0002_b.gif)
Figure 3. Effect of FRFE on transfer latency in scopolamine-induced amnesia (before learning). a,a*p < 0.05 as compared to Group I (naive) 1st and 2nd day respectively; b,b*p < 0.05 as compared to Group II (vehicle control) 1st and 2nd day respectively, and c,c*p < 0.05 as compared to Group V (FRFE 100 mg/kg) 1st and 2nd day respectively.
![Figure 3. Effect of FRFE on transfer latency in scopolamine-induced amnesia (before learning). a,a*p < 0.05 as compared to Group I (naive) 1st and 2nd day respectively; b,b*p < 0.05 as compared to Group II (vehicle control) 1st and 2nd day respectively, and c,c*p < 0.05 as compared to Group V (FRFE 100 mg/kg) 1st and 2nd day respectively.](/cms/asset/f90b29fb-23d6-4be5-a68e-73e1d896d707/iphb_a_427304_f0003_b.gif)
Figure 4. Effect of FRFE on transfer latency in scopolamine-induced amnesia (before retrieval). ap < 0.05 as compared to Group VIII (naive), bp < 0.05 as compared to Group IX (vehicle control), and cp < 0.05 as compared to Group XII (FRFE 100 mg/kg).
![Figure 4. Effect of FRFE on transfer latency in scopolamine-induced amnesia (before retrieval). ap < 0.05 as compared to Group VIII (naive), bp < 0.05 as compared to Group IX (vehicle control), and cp < 0.05 as compared to Group XII (FRFE 100 mg/kg).](/cms/asset/65281ed4-4e68-4bfa-90d4-953f77023333/iphb_a_427304_f0004_b.gif)
Figure 5. Effect of FRFE on number of trials and mistakes in scopolamine-induced amnesia (before learning). a,a*p < 0.05 as compared to Group XV (naive) 1st and 2nd day respectively, b,b*p < 0.05 as compared to Group XVI (vehicle control) 1st and 2nd day respectively, and c,c*p < 0.05 as compared to Group XIX (FRFE 100 mg/kg) 1st and 2nd day respectively.
![Figure 5. Effect of FRFE on number of trials and mistakes in scopolamine-induced amnesia (before learning). a,a*p < 0.05 as compared to Group XV (naive) 1st and 2nd day respectively, b,b*p < 0.05 as compared to Group XVI (vehicle control) 1st and 2nd day respectively, and c,c*p < 0.05 as compared to Group XIX (FRFE 100 mg/kg) 1st and 2nd day respectively.](/cms/asset/62319d26-51f4-4794-945b-4f3a0d5ffed8/iphb_a_427304_f0005_b.gif)